Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Dumping 20M shares and keeping 10M warrants @$3.18

<< Previous

Bullboard Posts

Next >>

Comment by Wino115on Jan 28, 2021 1:11pm

97 Views

Post# 32410661

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Dumping 20M shares and keeping 10M warrants @$3.18

Good summary JFM. I would also point out that Dubuc has told a few people that the 3 instutional investors are long-term, so they likely have kept all their units. We can hope they've been the ones adding in this market.

FredTheVoice wrote: Very good post JFM.

I just hope you are a little wrong about the 6-9 months......in a way, I think great news for this company will come before your prediction....

Lets see,

GLTA,

FTV.